Display options
Cite
Stachs A, Hartmann S, Gerber B. Preservation of Fertility or Ovarian Function in Patients with Breast Cancer or Gynecologic and Internal Malignancies. Geburtshilfe Frauenheilkd. 2017;77(8):861-869doi: 10.1055/s-0043-116222.
Stachs, A., Hartmann, S., & Gerber, B. (2017). Preservation of Fertility or Ovarian Function in Patients with Breast Cancer or Gynecologic and Internal Malignancies. Geburtshilfe und Frauenheilkunde, 77(8), 861-869. https://doi.org/10.1055/s-0043-116222
Stachs, Angrit, et al. "Preservation of Fertility or Ovarian Function in Patients with Breast Cancer or Gynecologic and Internal Malignancies." Geburtshilfe und Frauenheilkunde vol. 77,8 (2017): 861-869. doi: https://doi.org/10.1055/s-0043-116222
Stachs A, Hartmann S, Gerber B. Preservation of Fertility or Ovarian Function in Patients with Breast Cancer or Gynecologic and Internal Malignancies. Geburtshilfe Frauenheilkd. 2017 Aug;77(8):861-869. doi: 10.1055/s-0043-116222. Epub 2017 Aug 24. PMID: 28845050; PMCID: PMC5570590.
Copy Download .nbib Format: NLM
Share it on

Geburtshilfe Frauenheilkd. 2017 Aug;77(8):861-869. doi: 10.1055/s-0043-116222. Epub 2017 Aug 24.

Preservation of Fertility or Ovarian Function in Patients with Breast Cancer or Gynecologic and Internal Malignancies.

Geburtshilfe und Frauenheilkunde

Angrit Stachs, Steffi Hartmann, Bernd Gerber

Affiliations

  1. Universitätsfrauenklinik Rostock, Rostock, Germany.

PMID: 28845050 PMCID: PMC5570590 DOI: 10.1055/s-0043-116222

Abstract

Because of the efficacy of systemic therapies, neoplasias which occur in pediatric and adolescent patients and in young adults have high cure rates. This means that fulfilling their wish to have children has become a more pressing concern, particularly among young women with malignant tumors. Premature ovarian failure is also a not insignificant problem as it has a lasting detrimental effect on quality of life. Every oncology patient who may potentially wish to have children should be informed about their options for preserving fertility prior to starting treatment. The rates of patient who received detailed briefing on this point remain low. This review presents the effects of different chemotherapeutic drugs on gonadal function together with an overview of currently valid recommendations on fertility preservation. Risk groups are defined and the specific approaches for malignancies of various organ systems are described. Cryopreservation of oocytes, fertilized embryos and ovarian tissue are fertility-preserving options for girls/young women. The data on the benefits of administering GnRH analogs for ovarian protection prior to starting chemotherapy are not clear. In postpubertal boys or male cancer patients, the standard approach is to cryopreserve sperm before starting therapy. The cryopreservation of testicular tissue is possible for prepubertal boys, however in-vitro sperm maturation is still in its experimental stages. This review also presents existing drug options for the preservation of ovarian function in oncology patients prior to chemotherapy, particularly for patients with (hormone-sensitive) breast cancer, and looks at the special issues of fertility-preserving surgery and radiation therapy in patients with gynecologic malignancies.

Keywords: breast cancer; chemotherapy; gynecolocic malignancies; infertility; irradiation; premature ovarian failure

References

  1. J Perinat Med. 2016 Nov 26;:null - PubMed
  2. Lancet Oncol. 2016 Jun;17 (6):e240-e253 - PubMed
  3. Reprod Biomed Online. 2008 Oct;17 (4):508-14 - PubMed
  4. Ann Oncol. 2016 Apr;27 Suppl 1:i20-i22 - PubMed
  5. Hum Reprod. 2016 Sep;31(9):2031-41 - PubMed
  6. BMC Cancer. 2016 May 27;16:337 - PubMed
  7. Int J Gynecol Cancer. 2016 Sep;26(7):1293-9 - PubMed
  8. Eur J Cancer. 2017 Apr;75:284-298 - PubMed
  9. Crit Rev Oncol Hematol. 2016 Jul;103:10-21 - PubMed
  10. Fertil Steril. 2015 Nov;104(5):1319-24 - PubMed
  11. J Obstet Gynaecol. 2016 Nov;36(8):1036-1040 - PubMed
  12. Lancet Oncol. 2005 Apr;6(4):209-18 - PubMed
  13. N Engl J Med. 2015 Mar 5;372(10):923-32 - PubMed
  14. Gynecol Oncol. 2016 Jul;142(1):50-53 - PubMed
  15. Eur J Cancer. 2017 Jan;71:25-33 - PubMed
  16. Breast Cancer. 2011 Jul;18(3):182-8 - PubMed
  17. Eur J Cancer. 2014 Sep;50(14):2367-74 - PubMed
  18. Acta Oncol. 2016 Jun;55(6):664-70 - PubMed
  19. Geburtshilfe Frauenheilkd. 2016 Oct;76(10 ):1057-1064 - PubMed
  20. J Clin Oncol. 2016 Jul 1;34(19):2221-31 - PubMed
  21. Obstet Gynecol. 2013 Jan;121(1):78-86 - PubMed
  22. Endocr Relat Cancer. 2014 Jan 21;21(1):R51-65 - PubMed
  23. J Clin Endocrinol Metab. 2006 May;91(5):1723-8 - PubMed
  24. Curr Opin Support Palliat Care. 2015 Sep;9(3):285-93 - PubMed
  25. J Clin Oncol. 2011 Jun 10;29(17):2334-41 - PubMed
  26. Breast Cancer Res Treat. 2009 Oct;117(3):561-7 - PubMed
  27. J Gynecol Oncol. 2017 Jan;28(1):e2 - PubMed
  28. Iran J Cancer Prev. 2013 Summer;6(3):147-50 - PubMed
  29. Acta Obstet Gynecol Scand. 2016 Sep;95(9):1015-26 - PubMed
  30. Gynecol Oncol. 2013 Oct;131(1):77-82 - PubMed
  31. Oncologist. 2014 Aug;19(8):814-22 - PubMed
  32. Int J Gynecol Cancer. 2014 May;24(4):718-28 - PubMed
  33. BJOG. 2006 Jun;113(6):719-24 - PubMed
  34. Gynecol Oncol. 2006 Nov;103(2):506-11 - PubMed
  35. Hum Reprod Update. 2016 Apr;22(3):null - PubMed
  36. Fertil Steril. 2010 Nov;94(6):2186-90 - PubMed
  37. Cancer. 2000 Apr 15;88(8):1877-82 - PubMed
  38. J Clin Oncol. 2013 Jul 1;31(19):2500-10 - PubMed
  39. J Clin Oncol. 2006 Mar 1;24(7):1045-51 - PubMed
  40. N Engl J Med. 2016 Aug 25;375(8):717-29 - PubMed
  41. Pediatrics. 2016 Oct;138(4):null - PubMed
  42. Breast. 2015 Nov;24 Suppl 2:S120-5 - PubMed
  43. Hum Reprod Update. 2012 Sep-Oct;18(5):525-35 - PubMed
  44. J Clin Oncol. 2013 Mar 20;31(9):1239-47 - PubMed
  45. Gynecol Oncol. 2015 Aug;138(2):304-10 - PubMed
  46. Eur J Cancer. 2013 Nov;49(16):3404-11 - PubMed
  47. Oncologist. 2014 Jan;19(1):68-74 - PubMed
  48. JAMA Oncol. 2016 Jan;2(1):65-73 - PubMed
  49. J Clin Oncol. 2012 Feb 10;30(5):533-8 - PubMed
  50. J Clin Endocrinol Metab. 1986 Mar;62(3):532-5 - PubMed
  51. Best Pract Res Clin Obstet Gynaecol. 2017 May;41:49-59 - PubMed
  52. Eur J Surg Oncol. 2014 Apr;40(4):387-93 - PubMed
  53. Gynecol Oncol. 2016 Jun;141(3):461-465 - PubMed
  54. Lancet Oncol. 2013 Aug;14(9):873-81 - PubMed
  55. Geburtshilfe Frauenheilkd. 2015 Dec;75(12):1243-1249 - PubMed
  56. Ann Oncol. 2015 Dec;26(12):2408-19 - PubMed
  57. Nat Rev Cancer. 2006 Nov;6(11):886-93 - PubMed
  58. J Breast Cancer. 2016 Dec;19(4):341-348 - PubMed
  59. Int J Womens Health. 2015 Sep 23;7:799-810 - PubMed
  60. Arch Gynecol Obstet. 2017 Apr;295(4):1033-1039 - PubMed
  61. J Assist Reprod Genet. 2015 Aug;32(8):1171-8 - PubMed
  62. Cancer Treat Rev. 2017 Feb;53:10-24 - PubMed
  63. Gynecol Oncol Res Pract. 2016 Oct 21;3:9 - PubMed
  64. Obstet Gynecol Surv. 2011 Aug;66(8):507-14 - PubMed
  65. Int J Gynaecol Obstet. 2016 Sep;134(3):282-5 - PubMed
  66. Ann Surg Oncol. 2010 Dec;17(12):3259-68 - PubMed
  67. Fertil Steril. 2009 Mar;91(3):694-7 - PubMed
  68. Zentralbl Gynakol. 1990;112(13):795-801 - PubMed
  69. JAMA. 2011 Jul 20;306(3):269-76 - PubMed
  70. Cancer. 2016 Jul 15;122(14 ):2216-23 - PubMed
  71. Minerva Ginecol. 2016 Oct;68(5):587-601 - PubMed
  72. Int J Gynaecol Obstet. 2016 Jul;134(1):49-52 - PubMed
  73. Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S152-6 - PubMed
  74. J Obstet Gynaecol. 2015 May;35(4):331-5 - PubMed
  75. Hum Reprod. 2017 Jan;32(1):154-164 - PubMed
  76. Arch Gynecol Obstet. 2014 Dec;290(6):1051-3 - PubMed
  77. Urology. 2016 May;91:190-6 - PubMed
  78. J Natl Cancer Inst. 2006 Jul 5;98(13):890-6 - PubMed
  79. Breast Cancer Res Treat. 2017 Jun 29;:null - PubMed
  80. Gynecol Oncol. 2016 Feb;140(2):234-8 - PubMed

Publication Types